INSULIN-LIKE GROWTH FACTOR II BINDING PROTEIN - ANVISA Registration 80464810322

Access comprehensive regulatory information for INSULIN-LIKE GROWTH FACTOR II BINDING PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810322 and manufactured by DEMEDITEC. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 2 companies making the same product including IMMUNODIAGNOSTICS SYSTEM LTD, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
2 Competitors
80464810322
Registration Details
ANVISA Registration Number: 80464810322
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80464810322

25351550950201330

09377976000152

Company Information

DEMEDITEC
Germany
PT: ALEMANHA

Dates and Status

Nov 11, 2013

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "INSULIN-LIKE GROWTH FACTOR II BINDING PROTEIN"